An mRNA vaccine encoding the Ebola virus glycoprotein induces high neutralizing antibody titers and provides strong protection against lethal infections in mouse models.
Stromberg ZR, Silva EE, Johnston SC, Johnson DM, Hall D, Adjei EF, Altin JA, Abisoye-Ogunniyan A, Gollott T, He W, Jones IKA, Kwilas S, Lund SJ, Mead HL, Nelson GA, Ouyang L, Peters SKG, Schwedler JL, Trecazzi CZ, Turner MW, Ye C, Bradfute SB, Fischer NO, Hooper JW, Ladner JT, Rasley A, Negrete OA.
Stromberg ZR, et al. Among authors: nelson ga.
Front Immunol. 2026 Jan 5;16:1682418. doi: 10.3389/fimmu.2025.1682418. eCollection 2025.
Front Immunol. 2026.
PMID: 41562068
Free PMC article.